The Most Common Cause of Hypothyroidism
Hashimoto’s thyroiditis — also known as Hashimoto’s disease or chronic lymphocytic thyroiditis — is the most common autoimmune disease in developed countries and the leading cause of hypothyroidism in iodine-sufficient regions. It affects an estimated 5% of the general population, with women affected 7–10 times more frequently than men. Despite its prevalence, Hashimoto’s is frequently misunderstood, underdiagnosed in its early stages, and inadequately treated even after diagnosis.
What Is Hashimoto’s Thyroiditis?
Hashimoto’s is an autoimmune condition in which the immune system produces antibodies that attack thyroid tissue — primarily thyroid peroxidase (TPO) antibodies and thyroglobulin (TgAb) antibodies. This immune attack causes progressive thyroid inflammation and damage, gradually reducing the gland’s ability to produce thyroid hormones. The disease typically progresses over years or decades, moving from a phase of normal or even elevated thyroid function (as damaged cells release stored thyroid hormone) through a hypothyroid state as thyroid tissue is destroyed.
Symptoms and the Diagnostic Challenge
Hashimoto’s can cause the full spectrum of hypothyroid symptoms — fatigue, weight gain, cold intolerance, constipation, brain fog, hair loss, depression, and dry skin. But because it progresses gradually and can fluctuate, symptoms are often dismissed as stress, aging, or depression. The diagnostic challenge is compounded by TSH-only testing: in early Hashimoto’s, TSH may be normal even as thyroid antibodies are actively destroying gland tissue. Measuring TPO and TgAb antibodies is essential for early identification of the autoimmune process.
Root Causes and Triggers
Hashimoto’s arises from a combination of genetic susceptibility and environmental triggers. Key triggers include: intestinal permeability (“leaky gut”) — allowing partially digested food proteins and bacterial components to cross the gut barrier and trigger immune responses; infections, particularly Epstein-Barr virus (EBV), which has been strongly implicated in Hashimoto’s onset; excessive iodine intake (paradoxically, too much iodine can trigger and worsen autoimmune thyroid disease in susceptible individuals); selenium deficiency — selenium is essential for thyroid hormone synthesis and glutathione-based antioxidant protection of thyroid tissue; psychological stress; and pregnancy (postpartum thyroiditis is a variant of Hashimoto’s triggered by the immune fluctuations of pregnancy).
Treatment: Beyond Levothyroxine
Standard treatment focuses on thyroid hormone replacement with levothyroxine when hypothyroidism develops. This is appropriate and necessary — but it does nothing to address the underlying autoimmune process. A comprehensive approach to Hashimoto’s management also addresses the root cause: gut healing protocols (eliminating food sensitivities, particularly gluten — a well-documented Hashimoto’s trigger in many patients — and healing intestinal permeability), selenium supplementation (200 mcg daily has been shown to significantly reduce TPO antibody levels in multiple clinical trials), stress management, optimal vitamin D levels, and addressing any infectious triggers. For patients whose symptoms persist on T4 alone, combination T4/T3 therapy or desiccated thyroid extract may produce better clinical outcomes.